Bioventus (BVS) Tax Provisions (2020 - 2026)
Bioventus (BVS) posted Tax Provisions of $571000.0 for Q1 2026, up 117.98% on a QoQ basis from -$3.2 million in Q4 2025, and up 701.05% year-over-year from $71281.2 in Q1 2025.
Bioventus (BVS) Tax Provisions (2020 - 2026) Analysis & Trends
Bioventus' Tax Provisions history runs 7 years deep, the most recent figure standing at $571000.0 for Q1 2026.
- Quarterly Tax Provisions rose 701.05% year-over-year to $571000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$899000.0 (up 85.72% YoY) and the FY2025 annual result came in at -$1.6 million, up 70.43% from the prior year.
- Tax Provisions was $571000.0 for Q1 2026 at Bioventus, up from -$3.2 million in the prior quarter.
- Across five years, Tax Provisions topped out at $1.2 million in Q3 2022 and bottomed at -$29.5 million in Q4 2022.
- A 5-year average of -$3.0 million and a median of $381000.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions tumbled 6930.14% — and 2024, when it soared 721.23%.
- Bioventus' Tax Provisions stood at -$11.0 million in 2022, then surged by 93.16% to -$750000.0 in 2023, then jumped by 173.33% to $550000.0 in 2024, then tumbled by 677.27% to -$3.2 million in 2025, then jumped by 117.98% to $571000.0 in 2026.
- Business Quant data shows BVS's Tax Provisions at $571000.0 in Q1 2026, -$3.2 million in Q4 2025, and $664000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 70.00 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 94.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -51.51 Mn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | 571,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 571,000.00 |
| Dec 31, 2025 | -3.18 Mn |
| Sep 27, 2025 | 664,000.00 |
| Jun 28, 2025 | 1.04 Mn |
| Mar 29, 2025 | -95,000.00 |
| Dec 31, 2024 | 550,000.00 |
| Sep 28, 2024 | 589,000.00 |
| Jun 29, 2024 | -7.34 Mn |
| Mar 30, 2024 | 907,000.00 |
| Dec 31, 2023 | -750,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jul 1, 2023 | 381,000.00 |
| Apr 1, 2023 | -146,000.00 |
| Dec 31, 2022 | -10.96 Mn |
| Oct 1, 2022 | -29.52 Mn |
| Jul 2, 2022 | 1.24 Mn |
| Apr 2, 2022 | -5.13 Mn |
| Dec 31, 2021 | -2.73 Mn |
| Oct 2, 2021 | -882,000.00 |
| Jul 3, 2021 | 1.71 Mn |